CR20120614A - Derivados de amino-tropano - Google Patents
Derivados de amino-tropanoInfo
- Publication number
- CR20120614A CR20120614A CR20120614A CR20120614A CR20120614A CR 20120614 A CR20120614 A CR 20120614A CR 20120614 A CR20120614 A CR 20120614A CR 20120614 A CR20120614 A CR 20120614A CR 20120614 A CR20120614 A CR 20120614A
- Authority
- CR
- Costa Rica
- Prior art keywords
- lower alkyl
- amino
- tropan
- derivatives
- tropan derivatives
- Prior art date
Links
- FHPZUVVXVRYZAS-SFYZADRCSA-N (1r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-5-amine Chemical class C1CC[C@@]2(N)CC[C@]1([H])N2C FHPZUVVXVRYZAS-SFYZADRCSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención, se refiere a compuestos de la fórmula general I, en donde, R1, R2 y R3, son, de una forma independiente la una con respecto a la otra, hidrógeno, alquilo inferior, alcoxi inferior, cicloalquilo, alquilo inferior sustituido por halógeno, ó S-alquilo inferior; o a sales de adición de ácidos, farmacéuticamente aceptables, a una mezcla racémica, o sus correspondientes enantiómeros y / o isómeros ópticos de ésta.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10166757 | 2010-06-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20120614A true CR20120614A (es) | 2013-01-11 |
Family
ID=44310862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20120614A CR20120614A (es) | 2010-06-22 | 2012-12-05 | Derivados de amino-tropano |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US8153653B2 (es) |
| EP (1) | EP2585456B1 (es) |
| JP (1) | JP5546684B2 (es) |
| KR (1) | KR101445016B1 (es) |
| CN (1) | CN102947297B (es) |
| AR (1) | AR081961A1 (es) |
| AU (1) | AU2011269145A1 (es) |
| BR (1) | BR112012032576A2 (es) |
| CA (1) | CA2801458C (es) |
| CL (1) | CL2012003552A1 (es) |
| CO (1) | CO6630160A2 (es) |
| CR (1) | CR20120614A (es) |
| EA (1) | EA201291374A1 (es) |
| EC (1) | ECSP12012347A (es) |
| ES (1) | ES2550831T3 (es) |
| IL (1) | IL222998A0 (es) |
| MA (1) | MA34251B1 (es) |
| MX (1) | MX2012013820A (es) |
| PE (1) | PE20130317A1 (es) |
| PH (1) | PH12012502339A1 (es) |
| SG (1) | SG186329A1 (es) |
| TW (1) | TWI417097B (es) |
| WO (1) | WO2011161006A1 (es) |
| ZA (1) | ZA201209248B (es) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3238414B2 (ja) * | 1996-02-22 | 2001-12-17 | ニューロサーチ・アクティーゼルスカブ | トロパン―誘導体、その製造方法及びその使用方法 |
| US5834484A (en) * | 1997-03-12 | 1998-11-10 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Cocaine analogs |
| PT1663232E (pt) * | 2003-09-09 | 2007-12-12 | Hoffmann La Roche | Derivados de 1- (2-amino-benzol) -piperazina como inibidores de absorção de glicina para o tratamento de psicoses |
| FR2861076B1 (fr) * | 2003-10-17 | 2006-01-06 | Sanofi Synthelabo | Derives de n-heterocyclymethylbenzamide, leur preparation et leur application en therapeutique |
| JP2007535538A (ja) * | 2004-04-29 | 2007-12-06 | メルク エンド カムパニー インコーポレーテッド | アゼチジングリシン輸送体インヒビター |
| FR2873693B1 (fr) * | 2004-07-29 | 2006-09-15 | Sanofi Synthelabo | Derives d'amino-tropane, leur preparation et leur application en therapeutique |
| GB0428231D0 (en) * | 2004-12-23 | 2005-01-26 | Glaxo Group Ltd | Compounds |
| CA2593453A1 (en) * | 2005-01-06 | 2006-07-13 | F. Hoffmann-La Roche Ag | Sulfanyl substituted phenyl methanones as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| TW200846328A (en) * | 2007-02-01 | 2008-12-01 | Glaxo Group Ltd | GlyT1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| WO2010020548A1 (en) * | 2008-08-20 | 2010-02-25 | F. Hoffmann-La Roche Ag | Glyt1 receptor antagonists |
-
2011
- 2011-06-15 US US13/160,559 patent/US8153653B2/en not_active Expired - Fee Related
- 2011-06-17 SG SG2012091708A patent/SG186329A1/en unknown
- 2011-06-17 KR KR1020127033182A patent/KR101445016B1/ko not_active Expired - Fee Related
- 2011-06-17 EP EP11728224.4A patent/EP2585456B1/en active Active
- 2011-06-17 ES ES11728224.4T patent/ES2550831T3/es active Active
- 2011-06-17 PH PH1/2012/502339A patent/PH12012502339A1/en unknown
- 2011-06-17 AU AU2011269145A patent/AU2011269145A1/en not_active Abandoned
- 2011-06-17 CN CN201180030703.3A patent/CN102947297B/zh not_active Expired - Fee Related
- 2011-06-17 WO PCT/EP2011/060073 patent/WO2011161006A1/en not_active Ceased
- 2011-06-17 MA MA35398A patent/MA34251B1/fr unknown
- 2011-06-17 PE PE2012002444A patent/PE20130317A1/es not_active Application Discontinuation
- 2011-06-17 EA EA201291374A patent/EA201291374A1/ru unknown
- 2011-06-17 BR BR112012032576A patent/BR112012032576A2/pt active Search and Examination
- 2011-06-17 MX MX2012013820A patent/MX2012013820A/es active IP Right Grant
- 2011-06-17 JP JP2013515816A patent/JP5546684B2/ja not_active Expired - Fee Related
- 2011-06-17 CA CA2801458A patent/CA2801458C/en not_active Expired - Fee Related
- 2011-06-20 TW TW100121503A patent/TWI417097B/zh not_active IP Right Cessation
- 2011-06-21 AR ARP110102138A patent/AR081961A1/es unknown
-
2012
- 2012-10-26 CO CO12192372A patent/CO6630160A2/es active IP Right Grant
- 2012-11-12 IL IL222998A patent/IL222998A0/en unknown
- 2012-12-05 CR CR20120614A patent/CR20120614A/es unknown
- 2012-12-06 ZA ZA2012/09248A patent/ZA201209248B/en unknown
- 2012-12-17 CL CL2012003552A patent/CL2012003552A1/es unknown
- 2012-12-20 EC ECSP12012347 patent/ECSP12012347A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2012013820A (es) | 2013-01-28 |
| CN102947297A (zh) | 2013-02-27 |
| EA201291374A1 (ru) | 2013-06-28 |
| CO6630160A2 (es) | 2013-03-01 |
| JP5546684B2 (ja) | 2014-07-09 |
| KR20130029414A (ko) | 2013-03-22 |
| CN102947297B (zh) | 2015-12-16 |
| CA2801458C (en) | 2018-10-30 |
| CA2801458A1 (en) | 2011-12-29 |
| MA34251B1 (fr) | 2013-05-02 |
| ES2550831T3 (es) | 2015-11-12 |
| PH12012502339A1 (en) | 2013-02-11 |
| PE20130317A1 (es) | 2013-03-11 |
| TW201206438A (en) | 2012-02-16 |
| US8153653B2 (en) | 2012-04-10 |
| AR081961A1 (es) | 2012-10-31 |
| ECSP12012347A (es) | 2013-01-31 |
| KR101445016B1 (ko) | 2014-09-26 |
| CL2012003552A1 (es) | 2013-04-12 |
| IL222998A0 (en) | 2013-02-03 |
| US20110312993A1 (en) | 2011-12-22 |
| BR112012032576A2 (pt) | 2016-11-22 |
| SG186329A1 (en) | 2013-01-30 |
| AU2011269145A1 (en) | 2012-11-08 |
| EP2585456B1 (en) | 2015-09-16 |
| HK1179606A1 (zh) | 2013-10-04 |
| TWI417097B (zh) | 2013-12-01 |
| ZA201209248B (en) | 2013-08-28 |
| WO2011161006A1 (en) | 2011-12-29 |
| EP2585456A1 (en) | 2013-05-01 |
| JP2013529607A (ja) | 2013-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY33226A (es) | Compuestos de pirrolopirimidina deuterada como inhibidores de la cdk4/6 | |
| UY33227A (es) | Compuestos de pirrolopirimidina como inhibidores de la cdk4/6 | |
| AU2012313888A8 (en) | 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH | |
| AR082154A1 (es) | DERIVADOS DE PIRAZOLO[1,5-a]PIRIMIDINA COMO MODULADORES DE IRAK4 | |
| CR20120053A (es) | Compuestos y metodos inhibidores de jak de pirazolopirimidina | |
| CR20120410A (es) | Pirrolidina-2-carboxamidas sustituidas | |
| CR20140238A (es) | Derivados nucleósidos con sustitución 2´, 4´- difluoro-2´-metilo como inhibidores de la replicación del arn del vhc | |
| CR20140042A (es) | Indazoles | |
| CO6541606A2 (es) | Espiroindolinona- pirrolidinas | |
| CR20130476A (es) | Derivados de pirazolidin-3-ona | |
| EA201101147A1 (ru) | Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой | |
| CL2010000253A1 (es) | Procedimiento de preparacion de ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable; y uno de los compuestos intermediarios considerados. | |
| EA201391206A1 (ru) | Способы синтеза производных предшественника молибдоптерина z | |
| ECSP13012548A (es) | Inhibidores de oxadiazol de la producción de leucotrienos. | |
| CR20110275A (es) | 3-aminociclopentancarboxamidas como moduladores del receptor quimiocina | |
| CR20150158A (es) | Derivados de etinilo como moduladores de receptor de actividad mglur5 | |
| EA201200123A1 (ru) | Новый способ синтеза ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей | |
| CY1120784T1 (el) | Νεα κρυσταλλικη μορφη | |
| EA201000397A1 (ru) | Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой | |
| EA200900944A1 (ru) | Новый способ получения кристаллической формы v агомелатина | |
| MX2013009386A (es) | Nuevos compuestos de azaespirodecanona. | |
| UA113223C2 (xx) | Арилетинілпіримідини | |
| CR20120614A (es) | Derivados de amino-tropano | |
| AR082766A1 (es) | Derivados de quinolizidina e indolizidina | |
| BR112013004557A2 (pt) | novo processo. |